Current Edition

Upcoming Events

Advertisement

news

Bayer ends large blood thinner trial for ‘inferior efficacy’

Bayer is stopping a large clinical trial testing its experimental blood thinner asundexian in people with irregular heartbeats because it didn’t work as well as Bris...
Continue Reading →
news

AstraZeneca creates digital health unit, with big-name partnerships already in place

Dive Brief: AstraZeneca’s new health-tech business, Evinova, launched Monday, with several big-name partnerships already in place and a goal to “better meet the ...
Continue Reading →
news

Merck to buy private biotech Caraway in neuroscience deal

Dive Brief: Merck & Co. will pay as much as $610 million to acquire private biotechnology company Caraway Therapeutics in a deal that expands Merck’s researc...
Continue Reading →
news

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs 

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs  Pre-configured, scalable trial management system enables quicker s...
Continue Reading →
20th Annual Temperature Controlled Logistics in Biopharmaceuticals Europe 2024
Uncategorised

20th Annual Temperature Controlled Logistics in Biopharmaceuticals Europe 2024

Register now for the 20th Annual Temperature Controlled Logistics in Biopharmaceuticals Europe 2024 Conference taking place on the 6th-7th March 2024 in Barcelona, S...
Continue Reading →
news

Paper details Astellas gene therapy study that led to patient deaths

A new paper published online in The Lancet Neurology Wednesday provides key new details on a gene therapy study that left four patients dead and posed broader questi...
Continue Reading →
news

Lilly plans new $2.5B manufacturing plant as obesity drug demand ramps up

Dive Brief: Eli Lilly is spending $2.5 billion to build a new manufacturing plant to expand capacity for injectable drugs and devices, including its weight-loss ...
Continue Reading →
news

FDA approves new Bristol Myers drug for lung cancer

Dive Brief: The Food and Drug Administration on Wednesday approved Bristol Myers Squibb’s new lung cancer medication Augtyro, which the drugmaker believes will b...
Continue Reading →
news

Top FDA official Woodcock to retire early next year

Janet Woodcock, a top Food and Drug Administration official who had been on the short list to head the agency under President Joe Biden, will retire in early 2024 af...
Continue Reading →
20th Anglonordic Conference 2024
Events

20th Anglonordic Conference 2024

The Annual Anglonordic Life Science Conference is back for 2024. Join us on the 18th April for the 20th edition of this must-attend conference.  Date: ...
Continue Reading →